Boston, MA, United States of America

Xingwen Wu

This inventor holds 3 USPTO granted patents. Top assignee: Tufts University. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xingwen Wu. Retrieved from https://idiyas.com/inventor/xingwen-wu-uomnjxr1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xingwen Wu in Diabetes Treatment

Introduction

Xingwen Wu is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of diabetes-related complications. With a total of 3 patents, his work focuses on innovative approaches to address inflammation and bone diseases associated with diabetes.

Latest Patents

One of his latest patents involves the use of adiponectin receptor agonists to treat inflammation and bone diseases in diabetes. This patent discloses adiponectin receptor agonists and methods for utilizing them to treat inflammation or bone loss in affected subjects. His research aims to provide new therapeutic options for individuals suffering from these conditions.

Career Highlights

Xingwen Wu is affiliated with Tufts College, where he continues to advance his research and contribute to the academic community. His work has garnered attention for its potential impact on diabetes treatment and patient care.

Collaborations

He collaborates with esteemed colleagues, including Jinkun Chen and Qisheng Tu, to further enhance the scope and effectiveness of his research initiatives.

Conclusion

Xingwen Wu's innovative work in the field of diabetes treatment exemplifies the importance of research and development in addressing complex health issues. His contributions are paving the way for new therapeutic strategies that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…